Theoretical analysis of light and heavy-ion induced reactions: production of medically relevant <sup>97</sup>Ru-Reference-Cited by-同舟云学术

Theoretical analysis of light and heavy-ion induced reactions: production of medically relevant ⁹⁷Ru

Published:2024-02-14 Issue:7-8 Volume:112 Page:447-453
ISSN:0033-8230
Container-title:Radiochimica Acta
language:en
Short-container-title:

Author:

Sagwal Malvika¹^ORCID,Maiti Moumita¹^ORCID

Affiliation:

1. Department of Physics , Indian Institute of Technology Roorkee , Roorkee 247667 , Uttarakhand , India

Abstract

Abstract 97Ru is a key radionuclide sought for diagnostic imaging due to its low-energy and intense γ-rays of 215.7 keV and 324.5 keV. New reaction routes to produce this radionuclide are constantly being investigated. A crucial step in carrying out such reactions is a reliable beforehand estimate of the production cross section of radionuclide and optimization conditions through robust theoretical frameworks. Existing literature on α + 95Mo reaction has been freshly examined to understand the excitation function of 97Ru. The data have been compared to other reactions of different projectiles on medium-mass targets. The reaction codes pace4, empire-3.2.2, and talys-1.96 have been employed to decipher the reaction mechanism and check the predictive ability of underlying theoretical models. The yield of 97Ru at different projectile energies and thick target yield in the optimum energy range has also been determined from the theoretical modeling.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/ract-2023-0199/pdf

Reference46 articles.

1. Srivastava, S. C., Som, P., Meinken, G., Sewatkar, A., Ku, T. H. Ruthenium-97 Labeled Compounds – A New Class of Radiopharmaceuticals; Brookhaven National Laboratory Report BNL 24614, 1978.

2. Oster, Z. H., Som, P., Gil, M. C., Fairchild, R. G., Goldman, A. G., Schachner, E. R., Sacker, D. F., Atkins, H. L., Brill, A. B. Ruthenium-97 DTPA: a new radiopharmaceutical for cisternography. J. Nucl. Med. 1981, 22, 269.

3. Schachner, E. R., Gil, M. C., Atkins, H. L., Som, P., Srivastava, S. C., Badia, J., Sacker, D. F., Fairchild, R. G., Richards, P. Ruthenium-97 hepatobiliary agents for delayed studies of the biliary track I: Ru-97 PIPIDA: concise communication. J. Nucl. Med. 1981, 22, 352.

4. Zanzi, I., Srivastava, S. C., Meinken, G. E., Robeson, W., Mausner, L. F., Fairchild, R. G., Margouleff, D. A new cholescintigraphic agent: ruthenium-97-DISIDA. Nucl. Med. 1989, 16, 397; https://doi.org/10.1016/0883-2897(89)90107-4.

5. Som, P., Oster, Z. H., Matsui, K., Guglielmi, G., Persson, B. R. R., Pellettieri, M. L., Srivastava, S. C., Richards, P., Atkins, H. L., Brill, A. B. 97Ru-transferrin uptake in tumor and abscess. Eur. J. Nucl. Med. 1983, 8, 491; https://doi.org/10.1007/bf00598908.